Triazolopyridine compounds as PIM kinase inhibitors
申请人:Blake James F.
公开号:US08889704B2
公开(公告)日:2014-11-18
Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.